Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
Cameron Herberts, Matti Annala, Joonatan Sipola, et al.
Nature (2022) Vol. 608, Iss. 7921, pp. 199-208
Closed Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
Christopher Abbosh, Alexander M. Frankell, Thomas Harrison, et al.
Nature (2023) Vol. 616, Iss. 7957, pp. 553-562
Open Access | Times Cited: 163
Revealing influencing factors on global waste distribution via deep-learning based dumpsite detection from satellite imagery
Xian Sun, Dongshuo Yin, Fei Qin, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 46
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer
Nicolette M. Fonseca, Corinne Maurice‐Dror, Cameron Herberts, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping
Evan W. Warner, Kim Van der Eecken, Andrew J. Murtha, et al.
Nature Cancer (2024) Vol. 5, Iss. 1, pp. 114-130
Closed Access | Times Cited: 16
Regulated Induced Proximity Targeting Chimeras (RIPTACs): a Novel Heterobifunctional Small Molecule Therapeutic Strategy for Killing Cancer Cells Selectively
Kanak Raina, Chris D. Forbes, Rebecca Stronk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 26
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Arian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Cancer Research (2023) Vol. 83, Iss. 16, pp. 2763-2774
Open Access | Times Cited: 25
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation
Gian Marco Franceschini, Orsetta Quaini, Kei Mizuno, et al.
Cancer Discovery (2023) Vol. 14, Iss. 3, pp. 424-445
Open Access | Times Cited: 23
Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
Fabio Raith, Daniel H. O’Donovan, Clara Lemos, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2289-2289
Open Access | Times Cited: 21
Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up
Sia V. Lindskrog, Karin Birkenkamp‐Demtröder, Iver Nordentoft, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 23, pp. 4797-4807
Open Access | Times Cited: 20
Multimodal epigenetic sequencing analysis (MESA) of cell-free DNA for non-invasive colorectal cancer detection
Yumei Li, Jianfeng Xu, Chaorong Chen, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma
Iver Nordentoft, Sia V. Lindskrog, Karin Birkenkamp‐Demtröder, et al.
European Urology (2024) Vol. 86, Iss. 4, pp. 301-311
Open Access | Times Cited: 9
Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution
Irene Casanova‐Salas, Daniel Aguilar, Sarai Córdoba-Terreros, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1301-1312.e7
Open Access | Times Cited: 9
Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions
Joseph B. Hiatt, Anna-Lisa Doebley, Henry U. Arnold, et al.
Science Advances (2024) Vol. 10, Iss. 15
Open Access | Times Cited: 8
RNA vaccines for cancer: Principles to practice
Pablo Guasp, Charlotte Reiche, Zachary Sethna, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1163-1184
Closed Access | Times Cited: 7
Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature
Rolf I. Skotheim, Mari Bogaard, Kristina Totland Carm, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189080-189080
Open Access | Times Cited: 6
Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer
Gillian Vandekerkhove, Veda N. Giri, Susan Halabi, et al.
JCO Precision Oncology (2024), Iss. 8
Open Access | Times Cited: 6
Prostate cancer and liquid biopsies: Clinical applications and challenges
Fumihiko Urabe, Takayuki Sumiyoshi, Kojiro Tashiro, et al.
International Journal of Urology (2024) Vol. 31, Iss. 6, pp. 617-626
Open Access | Times Cited: 6
Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk and locally advanced prostate cancer: a multicenter, open-label, single-arm, phase II trial
Xuyu Zhang, Feng Zhou, Tong Lu, et al.
World Journal of Urology (2025) Vol. 43, Iss. 1
Closed Access
Clinical Utility of Serial Circulating Tumor DNA Analysis as a Minimally Invasive Biomarker in Advanced Urothelial Cancer
Toru Sakatani, Takayuki Sumiyoshi, Yuki Kita, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
In Memory of Dr. Felix Feng
Himisha Beltran
European Urology (2025)
Closed Access
Epigenomics‐guided precision oncology: Chromatin variants in prostate tumor evolution
Kira Furlano, Tina Keshavarzian, Nadine Biernath, et al.
International Journal of Cancer (2025)
Open Access
AR and YAP crosstalk: impacts on therapeutic strategies in prostate cancer
Guansong Zheng, Zhaojie Yan, Junrong Zou, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
Navonil De Sarkar, Robert D. Patton, Anna-Lisa Doebley, et al.
Cancer Discovery (2022) Vol. 13, Iss. 3, pp. 632-653
Open Access | Times Cited: 34
Fragmentomic analysis of circulating tumor DNA-targeted cancer panels
Kyle T. Helzer, Marina N. Sharifi, Jamie M. Sperger, et al.
Annals of Oncology (2023) Vol. 34, Iss. 9, pp. 813-825
Closed Access | Times Cited: 18
Genetic and Genomic Testing for Prostate Cancer: Beyond DNA Repair
Cameron Herberts, Alexander W. Wyatt, Paul L. Nguyen, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top